Sonazoid™ versus SonoVue<sup>®</sup> for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study-Reference-Cited by-同舟云学术

Sonazoid™ versus SonoVue^® for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study

Published:2022 Issue:11 Volume:23 Page:1067
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Kang Hyo-Jin¹²^ORCID,Lee Jeong Min¹²³^ORCID,Yoon Jeong Hee¹²^ORCID,Yoo Jeongin¹²^ORCID,Choi Yunhee⁴^ORCID,Joo Ijin¹²³^ORCID,Han Joon Koo¹²³^ORCID

Affiliation:

1. Department of Radiology, Seoul National University Hospital, Seoul, Korea.

2. Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.

3. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea.

4. Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.

Funder

College of Medicine, Seoul National University

Publisher

The Korean Society of Radiology

Subject

Radiology, Nuclear Medicine and imaging

Link

https://kjronline.org/pdf/10.3348/kjr.2022.0388

Reference42 articles.

1. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules

2. Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR)

3. Tips and Tricks in Contrast-Enhanced Ultrasound (CEUS) for the Characterization and Detection of Liver Malignancies

4. Characterization of Focal Liver Lesions with Contrast-specific US Modes and a Sulfur Hexafluoride–filled Microbubble Contrast Agent: Diagnostic Performance and Confidence

5. Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfluorobutane application value in microwave ablation of small hepatocellular carcinoma (<3 cm);Clinical Hemorheology and Microcirculation;2024-07-25

2. Ultrasound-Based Micro-/Nanosystems for Biomedical Applications;Chemical Reviews;2024-06-26

3. Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis;Medical Ultrasonography;2024-06-21

4. Updates on the Diagnostic Use of Ultrasonography Augmented With Perfluorobutane Contrast in Hepatocellular Carcinoma: A Meta-Analysis;Cureus;2024-05-23

5. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma;Abdominal Radiology;2024-04-07